Navigation Links
Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain
Date:10/4/2010

under recognized and inadequately managed, affects up to 95% of all cancer patients.  FPNS' proprietary pectin-based transmucosal delivery system is characterized by reduced time to onset of effect, which helps overcome one limitation associated with treatment by conventional opioids."  

Notes to editors:About Archimedes PharmaArchimedes Pharma is an international specialty pharmaceutical company focused on the oncology, pain, neurology, and critical care sectors. Archimedes Pharma is marketing an expanding portfolio of specialist products to hospital-based prescribers in Europe and has established commercial organizations in the UK, US, France, Germany, Ireland, and Spain.

Archimedes Pharma's portfolio includes an innovative fentanyl nasal spray, PecFent®, approved in Europe for the treatment of breakthrough cancer pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain, and is under review by the US Food and Drug Administration (FDA).

PecFent®

PecFent is an innovative fentanyl citrate nasal spray that has been granted Marketing Authorization by the European Medicines Agency for the treatment of breakthrough cancer pain in adults who are already receiving maintenance opioid therapy for chronic cancer pain.

About Breakthrough Cancer Pain (BTCP)

Breakthrough cancer pain affects up to 95% of all cancer patients with pain and is characterized by sudden, unpredictable episodes of intense pain that occur despite background pain medication. This pain is rapid in onset, usually reaching maximum intensity in five minutes and lasting for 30 to 60 minutes.

For more information, please visit: www.archimedespharma.com.Media contacts:Tiberend Strategic Advisors, Inc. (USA)Tamara Bright/Andrew Mielach +1 212-827-0020 tbright@tiberendstrategicadvisors.com/

SOURCE Archimedes Pharma
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Archimedes Pharma Announces Successful Proof-of-Concept Results on Two Intranasal Development Projects
2. Archimedes Pharma Receives CHMP Positive Opinion for PecFent(R) for the Treatment of Breakthrough Cancer Pain
3. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
10. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
11. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... , Aug. 26, 2014  Royal Philips (NYSE: PHG, ... company,s latest innovation designed to empower seniors to live ... the company,s leading U.S.-based call center, the mobile app ... recent survey by Philips and the Global ... School of Business, 96 percent of senior respondents ...
(Date:8/26/2014)... --   Practice Fusion , the country,s largest cloud-based ... addition to its executive team of Tom Langan ... Joe Priest as the company,s vice president of ... hire of Robert Park as its chief financial officer, ... bench. With the addition of two industry veterans, these ...
(Date:8/26/2014)... DIEGO , Aug. 26, 2014   Tocagen ... has been named vice president, clinical development, and ... clinical operations. "As we advance Toca ... are expanding our clinical team with individuals who have ... commercialization activities," said Jamey Skillings , M.D., Chief ...
Breaking Medicine Technology:Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 2Philips Lifeline introduces response app to connect seniors with access to help in the event of an emergency 3Practice Fusion Further Expands Executive Team with Chief Commercial Officer and VP of Pharmaceutical Partnerships Hires 2Practice Fusion Further Expands Executive Team with Chief Commercial Officer and VP of Pharmaceutical Partnerships Hires 3Tocagen Expands Clinical Development Team; 2Tocagen Expands Clinical Development Team; 3
... , , THOUSAND OAKS, ... today announced positive top-line results from a Phase 3 trial ... as a second-line treatment in 1,186 patients with metastatic colorectal ... overall survival. , , Vectibix significantly ...
... , , , ... a world-leading developer and marketer of innovative medical technologies for ... data demonstrating positive clinical results achieved with the Engenex((R)) Advanced ... , The Engenex((R)) NPWT System, utilizing low ...
Cached Medicine Technology:Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 2Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 3Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 4Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 5Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 6Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 7Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer 8New Data Supports ConvaTec Negative Pressure Wound Therapy 2New Data Supports ConvaTec Negative Pressure Wound Therapy 3
(Date:8/27/2014)... PCOS (Polycystic Ovarian Syndrome) affects an ... risk for a number of health disorders and medical ... understood even within the medical community. Many women are ... and excess body fat around the waist area (truncal ... are caused by PCOS. , Awareness is the first ...
(Date:8/27/2014)... 2014 iHire was recognized for ... “Most Creative Workplace” in Frederick, a new category ... Work Awards. , Held at the Delaplaine Visual ... joint partnership between the Frederick County Workforce Services, ... County Business Development and Retention, and Frederick County ...
(Date:8/26/2014)... August 27, 2014 Hearing aids ... be hard for plan holders to determine what their hearing ... participating in several additional health plans and has published benefit ... assistance page . , The following is a list ... a participating provider: , NYSHIP/ NYS Empire Plan - Hearing ...
(Date:8/26/2014)... AlignLife of Wauwatosa held its second annual Thanksgiving in July ... collect at least 300lbs of food for our local Hunger ... not only reach this goal, but also had us way ... of food during their month-long food drive. , "We definitely ... Sam. "We look forward to collecting well over the 600lb ...
(Date:8/26/2014)... 27, 2014 A Forever Recovery, ... their annual alumni picnic on Saturday, August 17, with ... Snake” Roberts. , Each year, graduates from all over ... while several share their own story during the open ... are still in the program. , Roberts, who was ...
Breaking Medicine News(10 mins):Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:iHire Named Most Creative Workplace in Frederick, MD 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 2Health News:East End Hearing of Long Island Now Participating in Many Local Health Plans 3Health News:AlignLife Wauwatosa Thanksgiving in July Yields over 500 lbs of Food 2Health News:A Forever Recovery Wraps Up Successful Annual Alumni Picnic Featuring Former Pro Wrestler Jake “The Snake” Roberts 2Health News:A Forever Recovery Wraps Up Successful Annual Alumni Picnic Featuring Former Pro Wrestler Jake “The Snake” Roberts 3
... Internationally renowned scientist Dr. Huda Zoghbi, a pioneer in ... disorders, will receive the 2009 Vilcek Prize in biomedical ... 2006," said Dr. Jan Vilcek, President and Cofounder of ... announce the expansion of our awards program with the ...
... Help Companies Design, Prototype and Deploy Medical Devices Faster ... Instruments (Nasdaq: NATI ) today announced it ... development by offering software and training grants in ... device industry continues to thrive. A recent study of ...
... to Sponsor the Congenital Heart Futures Act - ... Disease Registry, Congenital Heart Defect Research and EducationCHICAGO, ... - the country,s leading organization solely dedicated to ... organizations participating in National Congenital Heart Lobby Day ...
... 9 ARKRAY USA, Inc., the 5th largest,Blood Glucose ... U.S. Food and Drug Administration for the GLUCOCARD(R) 01-mini ... new system requires no coding, displays results in 7 ... was developed to use the same,affordable test strips as ...
... Feb. 9 Global multiservice public relations,agency ... live panel discussion,titled "Healthcare Communications in the ... Regulated Environment." The presentation will take place ... the company,s Washington, D.C., office and be,available ...
... Denver Announces New Hospitalist PartnerTACOMA, Wash., Feb. 9 ... Hospital) has selected Sound Inpatient Physicians(TM) (Sound) to ... care at its Denver facility."Selecting an experienced hospitalist ... promise to elevate patient care to ambitious new ...
Cached Medicine News:Health News:Dr. Huda Zoghbi to receive 2009 Vilcek Prize in biomedical research 2Health News:Dr. Huda Zoghbi to receive 2009 Vilcek Prize in biomedical research 3Health News:Dr. Huda Zoghbi to receive 2009 Vilcek Prize in biomedical research 4Health News:Dr. Huda Zoghbi to receive 2009 Vilcek Prize in biomedical research 5Health News:Dr. Huda Zoghbi to receive 2009 Vilcek Prize in biomedical research 6Health News:National Instruments to Further Medical Device Development With Grants in 2009 2Health News:National Instruments to Further Medical Device Development With Grants in 2009 3Health News:National Instruments to Further Medical Device Development With Grants in 2009 4Health News:The Children's Heart Foundation to Support National Congenital Heart Coalition (NCHC) on Capitol Hill by Participating in National Congenital Heart Lobby Day on February 10 2Health News:The Children's Heart Foundation to Support National Congenital Heart Coalition (NCHC) on Capitol Hill by Participating in National Congenital Heart Lobby Day on February 10 3Health News:ARKRAY USA Receives FDA Clearance on GLUCOCARD(R) 01-mini Blood Glucose Monitoring System 2Health News:Healthcare Online Regulations Discussed in Live Event and Webcast Hosted by Waggener Edstrom Worldwide 2Health News:Sound Inpatient Physicians Expands to Long-Term Acute Care Facilities 2
... The UNFOLDER Silver-T is a refinement of ... to use. Offering proven ease of implantation, The ... lens 2-1/2 times faster than The UNFOLDER Silver ... a single twist, yet The UNFOLDER Silver-T provides ...
... contains a plunger style advance, or a ... for multiple use. The injector is made ... STAAR cartridges. These injectors are sold sterile, ... This system was designed specifically for easy ...
... Laserex Ultra Q is the fundamental capsulotmy laser ... energy delivery and provides 2855% less energy in ... mJs in contemporary systems. This technology eliminates ... the risk of IOL pitting. , , ...
... The Ultrasonix ES500 system is an ... system that provides excellent clinical performance. ... software processing of the ES500 system ... penetration and every system offers a ...
Medicine Products: